As of 2025-10-20, the Intrinsic Value of XBiotech Inc (XBIT) is -4.62 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.49 USD, the upside of XBiotech Inc is -285.48%.
Based on its market price of 2.49 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 285.48%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.62 - -4.62 | -4.62 | -285.48% |
| P/E | (6.28) - (10.51) | (7.97) | -419.9% |
| DDM - Stable | (7.22) - (20.94) | (14.08) | -665.4% |
| DDM - Multi | (9.02) - (20.64) | (12.59) | -605.5% |
| Market Cap (mil) | 75.92 |
| Beta | 1.37 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -77.02 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.46% |
| Cost of Debt | 5.00% |
| WACC | 9.80% |